3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Subsegmental resection preserves regional pulmonary function: A focus on thoracoscopy

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The aim of this study was to evaluate regional postoperative preserved pulmonary function (PPPF) and three‐dimensional (3D) volumetric changes according to the number of resected subsegments and investigate the factors that most affected pre‐/post PPPF.

          Methods

          Patients who underwent thoracoscopic lobectomy ( n = 73), and segmentectomy ( n = 87) were eligible for inclusion in the study. They were classified according to the number of resected subsegments which ranged from 1 to 10. The percentage of pre‐/postoperative forced expiratory volume in 1 s (FEV1) was used for comparison. Furthermore, lung volumetric changes were calculated using 3D computed tomography (CT) volumetry.

          Results

          The percentage of pre‐/postoperative EFV1 between 4 and 5–7 and between 5–7 and 10 were significant ( p = 0.03 and p < 0.01, respectively), but not between 1–2 to 4 ( p = 0.99). The difference between volumetric changes in the left lower lobe of patients with a number of resected subsegments was significant ( p < 0.01). On univariate and multivariate analyses, chronic inflammation was significant for decrease in recovery percentages. When the PPPF was compared among resected subsegments, it gradually decreased with an increase in the number of patients without a postoperative procrastination of inflammation ( p < 0.01).

          Conclusions

          Segmentectomy is feasible and useful for PPPF. Even a relatively large‐volume resection procedure where 5–7 subsegments are resected can preserve pulmonary function. Chronic inflammation was statistically identified as a risk factor for postoperative preserved pulmonary function.

          Key points

          Abstract

          Segmentectomy is feasible and useful for postoperative preserved pulmonary function. However, chronic inflammation has been statistically identified as a risk factor for postoperative preserved pulmonary function.

          Related collections

          Most cited references28

          • Record: found
          • Abstract: found
          • Article: not found

          Segmental resection spares pulmonary function in patients with stage I lung cancer.

          Segmental resection for stage I non-small cell lung cancer remains controversial. Reports suggest that segmentectomy confers no advantage in preserving lung function and compromises survival. This study was undertaken to assess the validity of those assertions. We retrospectively analyzed patients undergoing lobectomy (n = 147) or segmentectomy (n = 54) for stage I non-small cell lung cancer between March 1996 and June 2001. All patients were included in the survival analysis. Pulmonary function testing was obtained preoperatively and at 1 year and included forced vital capacity, forced expiratory volume in 1 second, maximum voluntary ventilation, diffusing capacity, and stair-stepper exercise. Patients with recurrent disease (lobectomy, n = 32; segmentectomy, n = 10) were excluded in the pulmonary function testing analysis to avoid the confounding variables of tumor or treatments. Preoperative pulmonary function tests in segmentectomy patients were significantly reduced compared with lobectomy (forced expiratory volume in 1 second, 75.1% versus 55.3%; p < 0.001). At 1 year, lobectomy patients experienced significant declines in forced vital capacity (85.5% to 81.1%), forced expiratory volume in 1 second (75.1% to 66.7%), maximum voluntary ventilation (72.8% to 65.2%), and diffusing capacity (79.3% to 69.6%). In contrast, a decline in diffusing capacity was the only significant change seen after segmental resection. Oxygen saturations at rest and with exercise were maintained in both groups. Actuarial survival in both groups was similar (p = 0.406) with a 1-year survival of 95% for lobectomy and 92% for segmentectomy. Four-year survivals were 67% and 62%, respectively. For patients with stage I non-small cell lung cancer, segmental resection offers preservation of pulmonary function compared with lobectomy and does not compromise survival. Segmentectomy should be considered whenever permitted by anatomic location.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Functional advantage after radical segmentectomy versus lobectomy for lung cancer.

            Although several reports have recently demonstrated that segmentectomy for small-sized N0 lung cancer leads to recurrence and survival rates equivalent to those associated with lobectomy, controversy regarding the postoperative functional advantage in the former over the latter still persists. The purpose of this study was to evaluate the degree of postoperative functional loss in patients undergoing segmentectomy or lobectomy for lung cancer. We analyzed patients able to tolerate lobectomy, who underwent radical segmentectomy (n = 38) or lobectomy (n = 45) for non-small-cell lung cancer. Functional testing included forced vital capacity, forced expiratory volume in 1 second, and anaerobic threshold measured preoperatively and at 2 and 6 months after surgery. Preoperative function tests showed no differences between segmentectomy and lobectomy patients. A positive and significant correlation was found between the number of resected segments versus loss of forced vital capacity (r = 0.518, p < 0.0001 at 2 months; r = 0.604, p < 0.0001 at 6 months) and loss of forced expiratory volume in 1 second (r = 0.492, p < 0.0001 at 2 months; r = 0.512, p < 0.0001 at 6 months). The postoperative reduction of forced vital capacity (p = 0.0006) and forced expiratory volume in 1 second (p = 0.0007) was significantly less in the segmentectomy group; however, a marginally significant benefit was observed in this group for anaerobic threshold (p = 0.0616). The extent of removed lung parenchyma directly affected that of postoperative functional loss even at 6 months after surgery, and segmentectomy offered significantly better functional preservation compared with lobectomy. These results indicate the importance of segmentectomy for early staged lung cancer.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Better pulmonary function and prognosis with video-assisted thoracic surgery than with thoracotomy.

              Data regarding pulmonary function and prognosis after video-assisted thoracic surgery lobectomy are limited. From September 1992 to April 2000, 204 video-assisted thoracic surgery lobectomies were performed, and their preoperative and postoperative pulmonary function test results and prognoses were evaluated. The postoperative to preoperative ratio of pulmonary function tests (vital capacity and forced expiratory volume in 1 s) were better in video-assisted thoracic surgery lobectomy than in open thoracotomy (p < 0.0001). Furthermore, the 5-year survival rate of pathologic stage I lung cancers after video-assisted thoracic surgery was 97.0%, whereas that after open thoracotomy was 78.5% (p = 0.0173; Mantel-Cox). Pulmonary function and prognosis were far better after video-assisted thoracic surgery lobectomy than after open thoracotomy.
                Bookmark

                Author and article information

                Contributors
                h-kuroda@aichi-cc.jp
                Journal
                Thorac Cancer
                Thorac Cancer
                10.1111/(ISSN)1759-7714
                TCA
                Thoracic Cancer
                John Wiley & Sons Australia, Ltd (Melbourne )
                1759-7706
                1759-7714
                14 February 2021
                April 2021
                : 12
                : 7 ( doiID: 10.1111/tca.v12.7 )
                : 1033-1040
                Affiliations
                [ 1 ] Department of Thoracic Surgery Aichi Cancer Center Hospital Nagoya Japan
                [ 2 ] Department of Translational Oncoimmunology Aichi Cancer Research Institute Nagoya Japan
                [ 3 ] Department of Surgery, Division of Thoracic Surgery The Teikyo University Tokyo Japan
                Author notes
                [*] [* ] Correspondence

                Hiroaki Kuroda, Department of Thoracic Surgery, Aichi Cancer Center, 1‐1 Kanokoden, Chikusa‐ku, Nagoya 464‐8681, Japan.

                Email: h-kuroda@ 123456aichi-cc.jp

                Author information
                https://orcid.org/0000-0001-7292-0293
                https://orcid.org/0000-0003-1168-0163
                Article
                TCA13841
                10.1111/1759-7714.13841
                8017248
                33586330
                f0026c3a-69d7-4e01-98c6-6cb0238cffd5
                © 2021The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 29 December 2020
                : 13 December 2020
                : 31 December 2020
                Page count
                Figures: 4, Tables: 3, Pages: 8, Words: 4971
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                April 2021
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.0.1 mode:remove_FC converted:02.04.2021

                forced expiratory volume,left upper lobe,lobectomy,segmentectomy,thoracoscopic surgery

                Comments

                Comment on this article